VSTM

Verastem, Inc. News Headlines

$6.06
*  
0.46
8.21%
Get VSTM Alerts
*Delayed - data as of Aug. 28, 2015 12:57 ET  -  Find a broker to begin trading VSTM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VSTM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Will Galena's Initiatives Translate Into Positive Returns?
9/28/2013 5:09:00 PM - Seeking Alpha




6 Oncology-Focused Biotech Growth Engines: Mara Goldstein
8/2/2013 6:01:00 PM - Seeking Alpha






Has Smith & Nephew Found Its Next Target?
4/4/2013 10:55:00 AM - Seeking Alpha




IPO Market Update And Outlook
1/30/2013 10:57:00 AM - Seeking Alpha


The Worst Performing IPOs Of 2012
12/6/2012 6:14:00 AM - Seeking Alpha




Winning the Biotech Game
3/22/2012 10:45:10 AM - Josh Levine




Upgrades Lead To Optimism In Cancer Stem Cell Therapy
3/13/2012 6:08:00 AM - Seeking Alpha




Thinking Of Spring: Tulips And Cancer Stem Cell Mania
3/5/2012 11:26:00 AM - Seeking Alpha






Caesars Stands Out In A Busy IPO Week With Strong Returns
2/12/2012 5:47:00 AM - Seeking Alpha




ImmunoCellular And Cancer Treatment's Next Frontier
2/8/2012 12:41:00 PM - Seeking Alpha




Verastem: Killing Cancer At The Root
2/2/2012 6:55:00 AM - Seeking Alpha






The IPO Buzz: IPO Clouds With Silver Linings
1/25/2012 11:25:00 AM - Seeking Alpha